Movatec (Meloxicam)

Meloxicam, the active ingredient in Movatec, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as a sterile injectable solution for intramuscular use. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and other musculoskeletal conditions.

GNH USA supplies Movatec as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide in accordance with EU quality standards and regulatory requirements. The company ensures consistent potency, safety, and traceability throughout the supply chain.

Meloxicam is an NSAID that reduces inflammation and pain in musculoskeletal disorders.

- Osteoarthritis: alleviates joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: decreases joint inflammation and pain in chronic autoimmune arthritis. - Acute musculoskeletal pain: provides rapid analgesia for short‑term inflammatory pain following injury or surgery.

Adverse reactions to meloxicam may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Injection site reactions: erythema, swelling, or pain. - Edema: peripheral swelling, especially in the lower limbs.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: increased risk of thrombotic events.

Before prescribing meloxicam, clinicians should consider the following precautions. - Assess renal function: avoid use in patients with severe renal impairment. - Evaluate hepatic status: use cautiously in liver disease. - Monitor gastrointestinal risk: patients with history of ulcers or bleeding need protection. - Cardiovascular caution: avoid in uncontrolled hypertension or recent myocardial infarction. - Pregnancy and lactation: contraindicated unless benefits outweigh risks (unknown category). - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Meloxicam may interact with several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of renal impairment and electrolyte imbalance. - Lithium: increased lithium levels leading to toxicity.